{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:50:28Z","timestamp":1787878228279,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The goal of this study was to see if using mirabegron, solifenacin, or placebo may help patients with transurethral resection avoid catheter-related bladder discomfort (CRBD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients who underwent transurethral surgery and were given a catheter for 3 days after surgery were chosen for this study. The enrolled patients were separated into 3 groups: mirabegron (M), solifenacin (S), and a blank control group (C). All patients had their overactive bladder symptoms score (OABSS) and blood pressure checked before surgery. The CRBD, blood pressure, and heart rate were measured at 6, 24, 48, and 72 hours after surgery. The OABSS and side effects were documented on the 7<jats:sup>th<\/jats:sup> day.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The 104 patients in this trial were randomized into 3 groups at random: M, S, and C. The ultimate follow-up was completed by 99 patients, including 33 in group M, 33 in group S, and 33 in group C. The OABSS, CRBD, and blood pressure in groups M and S were similar before and after surgery (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Groups M and S performed much better on the OABSS and CRBD than group C (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). There were no significant differences in blood pressure between the 3 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). There were no significant differences in the occurrences of new onset dry mouth (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.84) or constipation (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.64) among the 3 groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Mirabegron is comparable to solifenacin as an alternative for the prevention of CRBD, making it a viable option for CRBD prevention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032052","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T16:01:12Z","timestamp":1670515272000},"page":"e32052","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Study of mirabegron and solifenacin in the improvement of catheter-related bladder discomfort in patients undergoing transurethral resection: A case\u2013control study"],"prefix":"10.1097","volume":"101","author":[{"given":"Bohan","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwu","family":"Shen","sequence":"additional","affiliation":[{"name":"Urology Department of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-5235","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"744244","DOI":"10.3389\/fsurg.2021.744244","article-title":"Incidence and risk factors of venous thromboembolism in patients after transurethral resection of the prostate (TURP)","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Surg"},{"key":"R2-20250504","first-page":"943","article-title":"Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate","volume":"17","author":"Meng","year":"2019","journal-title":"Exp Ther Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ane.0000167775.46192.e9","article-title":"The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study","volume":"101","author":"Agarwal","year":"2005","journal-title":"Anesth Analg"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clgc.2016.05.006","article-title":"Evaluation of the efficacy of solifenacin for preventing catheter-related bladder discomfort after transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer: a prospective, randomized, multicenter study","volume":"15","author":"Chung","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/ACO.0b013e32834c7b44","article-title":"Delirium in the postanaesthesia period.","volume":"24","author":"Guenther","year":"2011","journal-title":"Current Opin Anesthesiol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/bja\/aem232","article-title":"Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy","volume":"99","author":"Tauzin-Fin","year":"2007","journal-title":"Br J Anaesth"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/nau.22617","article-title":"Fourth international consultation on incontinence-research society 2013","volume":"33","author":"Abrams","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"R8-20250504","first-page":"867","article-title":"An evaluation of the efficacy of solifenacin and darifenacin for prevention of catheter related bladder discomfort: a prospective, randomized, placebo controlled, double blind study","volume":"82","author":"Srivastava","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/ael003","article-title":"Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study","volume":"96","author":"Agarwal","year":"2006","journal-title":"Br J Anaesth"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e4859e4859","DOI":"10.1097\/MD.0000000000004859","article-title":"Strategies for the prevention of catheter-related bladder discomfort: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Hu","year":"2016","journal-title":"Medicine"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1464-410X.2012.11023.x","article-title":"Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience","volume":"110","author":"Wagg","year":"2012","journal-title":"BJU Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1464-410X.2009.09036.x","article-title":"Patient\u2010reported reasons for discontinuing overactive bladder medication","volume":"105","author":"Benner","year":"2010","journal-title":"BJU Int"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia","volume":"384","author":"Brannan","year":"2021","journal-title":"N Engl J Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.eururo.2013.11.010","article-title":"Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison","volume":"65","author":"Maman","year":"2014","journal-title":"Eur Urol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eururo.2019.09.024","article-title":"Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo","volume":"77","author":"Chapple","year":"2020","journal-title":"Eur Urol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00540-014-1911-x","article-title":"The efficacy of pregabalin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled double-blind study","volume":"29","author":"Srivastava","year":"2015","journal-title":"J Anesth"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"16691459","DOI":"10.1155\/2021\/6691459","article-title":"The effect of transcutaneous electrical acupoint stimulation on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of the prostate.","volume":"2021","author":"Liang","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e13963","DOI":"10.1111\/ijcp.13963","article-title":"A randomised\u2010controlled, prospective study on the effect of dorsal penile nerve block after TURP on catheter\u2010related bladder discomfort and pain","volume":"75","author":"G\u00f6ger","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00540-019-02724-3","article-title":"Prophylactic diphenhydramine attenuates postoperative catheter-related bladder discomfort in patients undergoing gynecologic laparoscopic surgery: a randomized double-blind clinical study","volume":"34","author":"Li","year":"2020","journal-title":"J Anesth"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.urology.2014.02.034","article-title":"Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors","volume":"84","author":"Zhang","year":"2014","journal-title":"Urology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/nau.23919","article-title":"Long\u2010term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study","volume":"38","author":"Mueller","year":"2019","journal-title":"Neurourol Urodyn"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:31:19Z","timestamp":1746333079000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":22,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032052","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]}}}